These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29702054)

  • 1. Prevalence and Safety of Intravenous Immunoglobulin Administration During Maintenance Chemotherapy in Children with Acute Lymphoblastic Leukemia in First Complete Remission: A Health Maintenance Organization Perspective.
    Van Winkle P; Burchette R; Kim R; Raghunathan R; Qureshi N
    Perm J; 2018; 22():17-141. PubMed ID: 29702054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of IgG Monitoring and IVIG Supplementation on the Frequency of Febrile Illnesses in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Maintenance Chemotherapy.
    Holmes EA; Friedman DL; Connelly JA; Dulek DE; Zhao Z; Esbenshade AJ
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):423-428. PubMed ID: 30664103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
    Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
    Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: a retrospective cohort study.
    Huang LC; Myer L; Jaspan HB
    BMC Infect Dis; 2008 Sep; 8():127. PubMed ID: 18811982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low-dose intravenous immunoglobulin as the adjunctive therapy in septic shock patients with and without hypogammaglobulinemia: a retrospective cohort study.
    Goto K; Yasuda N; Sato Y
    Ann Palliat Med; 2022 Aug; 11(8):2600-2608. PubMed ID: 35695053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
    Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
    J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.
    Quartier P; Debré M; De Blic J; de Sauverzac R; Sayegh N; Jabado N; Haddad E; Blanche S; Casanova JL; Smith CI; Le Deist F; de Saint Basile G; Fischer A
    J Pediatr; 1999 May; 134(5):589-96. PubMed ID: 10228295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient hypogammaglobulinemia of infancy: intravenous immunoglobulin as first line therapy.
    Duse M; Iacobini M; Leonardi L; Smacchia P; Antonetti L; Giancane G
    Int J Immunopathol Pharmacol; 2010; 23(1):349-53. PubMed ID: 20378022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous immunoglobulin replacement therapy in 114 cases of congenital agammaglobulinemia].
    Li YW; Chen H; Zhang Y; An YF; Tang XM; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):495-500. PubMed ID: 34102824
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK
    J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonspecific immunoglobulin replacement in lung transplantation recipients with hypogammaglobulinemia: a cohort study taking into account propensity score and immortal time bias.
    Claustre J; Quétant S; Camara B; France M; Schummer G; Bedouch P; Pavese P; Saint Raymond C; Bardy B; Masson D; Roth H; Pison C;
    Transplantation; 2015 Feb; 99(2):444-50. PubMed ID: 25099705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG-ALL-2015.
    Zhu Y; Yang R; Cai J; Yu J; Tang Y; Chen Y; Wang N; He H; Wu X; Cheng FWT; Sun L; He Y; Ju X; Tian X; Hu Q; Jin R; Pan K; Fang Y; Zhai X; Jiang H; Li CK
    Cancer Med; 2020 Mar; 9(6):2113-2121. PubMed ID: 31994344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.
    Casulo C; Maragulia J; Zelenetz AD
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):106-11. PubMed ID: 23276889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous immunoglobulin in the treatment of infections in children with acute leukemias].
    Gebauer E; Tomić J; Stevanović S
    Med Pregl; 1994; 47(1-2):52-5. PubMed ID: 7739434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group.
    Wolff SN; Fay JW; Herzig RH; Greer JP; Dummer S; Brown RA; Collins RH; Stevens DA; Herzig GP
    Ann Intern Med; 1993 Jun; 118(12):937-42. PubMed ID: 8489107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogammaglobulinemia in infants receiving chronic peritoneal dialysis.
    Lalan S; Dai H; Warady BA
    Pediatr Nephrol; 2017 Mar; 32(3):503-509. PubMed ID: 27718085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
    Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
    Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N; Fouda M
    Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.